Narrator: This is Science Today. An effort to create an
implantable artificial kidney for dialysis patients has been given a boost by
the Food and Drug Administration. The University of California, San
Francisco-led project has been tapped by the FDA as one of the first projects
to undergo more timely and collaborative review. Bioengineer Shuvo Roy is leading a team of
about 40 researchers in nine laboratories nationwide to develop the artificial
Roy: What we are working on is a device the size of a coffee cup or slightly smaller that contains a mechanical filter that removes toxins from your blood, followed by another cartridge that contains cells. These cells process the filtrate and provide some of the functions that a healthy kidney does.
Narrator: Chronic kidney failure affects nearly 2 million people worldwide. The most effective treatment is kidney transplantation, but organs are in short supply, so many patients survive by undergoing dialysis.
Roy: Our device will provide therapy 24/7. It will allow the patient to be mobile. They don't have to be tethered to a machine.
Narrator: For Science Today, I'm Larissa Branin.